Almanack Investment Partners’s CareDx CDNA Stock Holding History

Almanack Investment Partners’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-415	Closed	-$7K	–	346
2022 Q3	$7K	Buy	+415	New	+$8.91K	﹤0.01%	527

Other funds holding CDNA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Almanack Investment Partners's CDNA Position: Q4 2022 in Review

Almanack Investment Partners sold out of CareDx (CDNA) in Q4 2022, closing a stake of 415 shares — an estimated $7K sold.

Almanack Investment Partners first reported a position in CDNA in Q3 2022 and held it in 1 quarter. The position peaked at $7K in Q3 2022. 168 funds tracked by Wall St. Rank hold CDNA as of Q4 2022.

Almanack Investment Partners reported no remaining CareDx position as of Q4 2022 after selling out during the quarter.
Almanack Investment Partners sold 415 CareDx shares in Q4 2022, an estimated $7K.
Almanack Investment Partners first reported a position in CareDx in Q3 2022 and held it in 1 quarter.
Almanack Investment Partners's CareDx position peaked at $7K in Q3 2022.
168 funds tracked by Wall St. Rank held CareDx as of Q4 2022.

Based on Almanack Investment Partners's 13F filing for Q4 2022, filed 9 Feb 2023.